Cancer Health Treatment Update CAR-NK Cells Show Promise for Blood Cancers Genetically modified natural killer cells led to remission in eight out of eleven patients with lymphoma or leukemia. CRISPR Gene Therapy Appears Feasible for Cancer Treatment Edited T cells survive and thrive in three patients in the first U.S. trial using this approach. What Are the Long-Term Side Effects of Prostate Cancer Treatment? A new five-year study identifies how different treatment options affect long-term bowel, bladder and sexual function. Fatty Liver, Alcohol Now the Leading Reasons for Liver Transplants Transplants due to hepatitis C have dropped dramatically, especially among people with liver cancer. Lung Cancer Screening Saves Even More Lives Than We Thought Annual screenings cut mortality rates by 24% in men and 33% in women.  News from the ASCO Gastrointestinal Cancers Symposium See all our latest coverage on colon, liver, pancreatic and other GI cancers. Cancer Health Winter 2020 Check out our latest print edition! Advertisement Newsfeed Trump's 2021 Budget Plan Slashes Cancer Funding—Again What Are the Long-Term Side Effects of Prostate Cancer Treatment? No Shield From X-Rays: How Science Is Rethinking Lead Aprons Believe in Miracles? You May Not Understand Your Terminal Cancer Prognosis Blog: National Cancer Institute Ayvakit Approved to Treat GIST With a Rare Gene Alteration Off Target: Investigating the Abscopal Effect as a Treatment for Cancer Changes in Metabolism Help Melanomas Spread Maintenance Therapy With CC-486 Extends Survival of Adults With AML Newsfeed Trump's 2021 Budget Plan Slashes Cancer Funding—Again What Are the Long-Term Side Effects of Prostate Cancer Treatment? No Shield From X-Rays: How Science Is Rethinking Lead Aprons Believe in Miracles? You May Not Understand Your Terminal Cancer Prognosis Blog: National Cancer Institute Ayvakit Approved to Treat GIST With a Rare Gene Alteration Off Target: Investigating the Abscopal Effect as a Treatment for Cancer Changes in Metabolism Help Melanomas Spread Maintenance Therapy With CC-486 Extends Survival of Adults With AML

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: